HK1197028A1 - Aromatic-cationic peptides and uses of same - Google Patents
Aromatic-cationic peptides and uses of sameInfo
- Publication number
- HK1197028A1 HK1197028A1 HK14110477A HK14110477A HK1197028A1 HK 1197028 A1 HK1197028 A1 HK 1197028A1 HK 14110477 A HK14110477 A HK 14110477A HK 14110477 A HK14110477 A HK 14110477A HK 1197028 A1 HK1197028 A1 HK 1197028A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- aromatic
- same
- cationic peptides
- peptides
- cationic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/07—Tetrapeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/095—Oxytocins; Vasopressins; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4891—Coated capsules; Multilayered drug free capsule shells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161496994P | 2011-06-14 | 2011-06-14 | |
US201161505479P | 2011-07-07 | 2011-07-07 | |
PCT/US2012/042261 WO2012174117A2 (en) | 2011-06-14 | 2012-06-13 | Aromatic-cationic peptides and uses of same |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1197028A1 true HK1197028A1 (en) | 2015-01-02 |
Family
ID=47357702
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK14110477A HK1197028A1 (en) | 2011-06-14 | 2014-10-21 | Aromatic-cationic peptides and uses of same |
Country Status (8)
Country | Link |
---|---|
US (1) | US20150118315A1 (ja) |
EP (1) | EP2720704A4 (ja) |
JP (1) | JP2014518213A (ja) |
CN (2) | CN103764159A (ja) |
AU (1) | AU2012271691A1 (ja) |
CA (1) | CA2839408A1 (ja) |
HK (1) | HK1197028A1 (ja) |
WO (1) | WO2012174117A2 (ja) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050282756A1 (en) | 2004-06-18 | 2005-12-22 | Mehta Nozer M | Oral delivery of peptide pharmaceutical compositions |
CA2772094C (en) | 2009-08-24 | 2018-04-03 | Stealth Peptides International, Inc. | Methods and compositions for preventing or treating ophthalmic conditions |
WO2014138241A1 (en) * | 2013-03-05 | 2014-09-12 | Enteris Biopharma, Inc. | Pharmaceuticals for oral delivery |
ES2901704T3 (es) | 2013-03-15 | 2022-03-23 | Protagonist Therapeutics Inc | Análogos de hepcidina y usos de los mismos |
US9850278B2 (en) | 2013-04-25 | 2017-12-26 | Carmel-Haifa University Economic Corp. | Synthetic anti-inflammatory peptides and use thereof |
AU2014324580B2 (en) * | 2013-09-30 | 2020-02-27 | Cornell University | Cardiolipin-targeted peptides inhibit beta-amyloid oligomer toxicity |
CA2935207C (en) | 2013-12-27 | 2022-06-21 | Stealth Biotherapeutics Corp | Pharmaceutically relevant aromatic-cationic peptides |
SG11201605790VA (en) * | 2014-01-22 | 2016-08-30 | Agency Science Tech & Res | Antimicrobial peptidomimetics |
EP3114136A4 (en) * | 2014-03-03 | 2017-11-01 | Stealth BioTherapeutics Corp | Pharmaceutically relevant aromatic-cationic peptides |
EP3960754A3 (en) | 2014-05-16 | 2022-07-06 | Protagonist Therapeutics, Inc. | Alpha4beta7 integrin thioether peptide antagonists |
SI3160984T1 (sl) | 2014-06-25 | 2021-08-31 | Flamma S.P.A. | Postopek za pripravo D-arginil-2,6-dimetil-L-tirosil-L-lisil-L-fenilalaninamida |
ES2890676T3 (es) | 2014-06-30 | 2022-01-21 | Flamma Spa | Procedimiento para la producción de D-arginil-2,6-dimetil-L-tirosil-L-lisil-L-fenilalaninamida |
SG10201810154WA (en) | 2014-07-17 | 2018-12-28 | Protagonist Therapeutics Inc | Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases |
SG11201702553RA (en) | 2014-10-01 | 2017-04-27 | Protagonist Therapeutics Inc | NOVEL α4β7 PEPTIDE MONOMER AND DIMER ANTAGONISTS |
ES2929218T3 (es) * | 2015-01-12 | 2022-11-28 | Enteris Biopharma Inc | Formas farmacéuticas orales sólidas |
CN107530395B (zh) | 2015-03-06 | 2021-10-22 | 康德生物医疗技术公司 | 制备药物相关肽的方法 |
US10787490B2 (en) | 2015-07-15 | 2020-09-29 | Protaganist Therapeutics, Inc. | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases |
CA3009834A1 (en) | 2015-12-30 | 2017-07-06 | Protagonist Therapeutics, Inc. | Analogues of hepcidin mimetics with improved in vivo half lives |
WO2017180535A1 (en) | 2016-04-11 | 2017-10-19 | Carnot, Llc | Chiral peptides |
WO2018187400A1 (en) | 2017-04-05 | 2018-10-11 | Stealth Biotherapeutics Corp. | Crystalline salt forms of boc-d-arg-dmt-lys-(boc)-phe-nh2 |
US10278957B2 (en) * | 2017-09-11 | 2019-05-07 | Protagonist Therapeutics, Inc. | Opioid agonist peptides and uses thereof |
US10676506B2 (en) | 2018-01-26 | 2020-06-09 | Stealth Biotherapeutics Corp. | Crystalline bis- and tris-hydrochloride salt of elamipretide |
WO2019157268A1 (en) | 2018-02-08 | 2019-08-15 | Protagonist Therapeutics, Inc. | Conjugated hepcidin mimetics |
MX2020012090A (es) * | 2018-05-16 | 2021-04-13 | Jiangsu Hengrui Medicine Co | Composicion farmaceutica del agonista del receptor de kor. |
KR20220044277A (ko) | 2019-07-10 | 2022-04-07 | 프로타고니스트 테라퓨틱스, 인코포레이티드 | 인터루킨-23 수용체의 펩티드 억제제 및 염증성 질환을 치료하기 위한 이의 용도 |
JP7441955B2 (ja) | 2020-01-15 | 2024-03-01 | ヤンセン バイオテツク,インコーポレーテツド | インターロイキン23受容体のペプチド阻害剤および炎症性疾患を治療するためのその使用 |
IL302996A (en) | 2020-11-20 | 2023-07-01 | Janssen Pharmaceutica Nv | Compositions of peptide inhibitors of the interleukin-23 receptor |
EP4166133A1 (en) * | 2021-10-13 | 2023-04-19 | Chugai Seiyaku Kabushiki Kaisha | Composition containing peptide compound and surfactant |
WO2023214509A1 (ja) * | 2022-05-02 | 2023-11-09 | 中外製薬株式会社 | 界面活性剤と併用するためのペプチド化合物を含む組成物 |
WO2024080308A1 (ja) * | 2022-10-12 | 2024-04-18 | 中外製薬株式会社 | ペプチド、界面活性剤及びポリマーを含む組成物 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101440124B (zh) * | 2003-02-04 | 2012-07-18 | 科内尔研究基金会 | 用于防止线粒体通透性改变的方法 |
EP2604621B1 (en) * | 2003-05-01 | 2015-10-21 | Cornell Research Foundation, Inc. | Method and carrier complexes for delivering molecules to cells |
CA2971929C (en) * | 2004-01-23 | 2019-01-08 | Cornell Research Foundation, Inc. | Methods for reducing oxidative damage |
US20050282756A1 (en) * | 2004-06-18 | 2005-12-22 | Mehta Nozer M | Oral delivery of peptide pharmaceutical compositions |
US8093207B2 (en) * | 2005-12-09 | 2012-01-10 | Unigene Laboratories, Inc. | Fast-acting oral peptide pharmaceutical products |
-
2012
- 2012-06-13 EP EP12801199.6A patent/EP2720704A4/en not_active Withdrawn
- 2012-06-13 CN CN201280039643.6A patent/CN103764159A/zh active Pending
- 2012-06-13 CN CN201510341661.5A patent/CN105126071A/zh not_active Withdrawn
- 2012-06-13 US US14/125,826 patent/US20150118315A1/en not_active Abandoned
- 2012-06-13 AU AU2012271691A patent/AU2012271691A1/en not_active Withdrawn
- 2012-06-13 CA CA2839408A patent/CA2839408A1/en not_active Abandoned
- 2012-06-13 JP JP2014515959A patent/JP2014518213A/ja not_active Abandoned
- 2012-06-13 WO PCT/US2012/042261 patent/WO2012174117A2/en active Application Filing
-
2014
- 2014-10-21 HK HK14110477A patent/HK1197028A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
CN105126071A (zh) | 2015-12-09 |
US20150118315A1 (en) | 2015-04-30 |
WO2012174117A2 (en) | 2012-12-20 |
CA2839408A1 (en) | 2012-12-20 |
EP2720704A4 (en) | 2015-06-10 |
JP2014518213A (ja) | 2014-07-28 |
AU2012271691A1 (en) | 2014-01-16 |
EP2720704A2 (en) | 2014-04-23 |
WO2012174117A3 (en) | 2013-03-28 |
CN103764159A (zh) | 2014-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1223550A1 (zh) | 芳香族陽離子肽及其用途 | |
HK1244540A1 (zh) | 芳香族陽離子肽及其用途 | |
HK1197028A1 (en) | Aromatic-cationic peptides and uses of same | |
HK1208686A1 (en) | Aromatic-cationic peptides and uses of same | |
HK1249406A1 (zh) | 芳族陽離子肽和使用它們的方法 | |
IL260045B (en) | Polypeptide structures and their uses | |
HK1201443A1 (en) | Aromatic-cationic peptides and uses of same | |
HK1199892A1 (en) | Modified mini-hepcidin peptides and methods of using thereof | |
EP2566880A4 (en) | AROMATIC-CATIONIC PEPTIDES AND USES THEREOF | |
IL230918A0 (en) | Modified proteins and peptides | |
HK1204772A1 (en) | Aromatic-cationic peptides and uses of same | |
EP2740741A4 (en) | PEPTIDE OBTAINED FROM THE WNT FAMILY AND USES THEREOF | |
EP2721061A4 (en) | STABILIZED VARIANT MAML PEPTIDES AND USES THEREOF | |
IL222027A (en) | Peptides and their use | |
EP2782589A4 (en) | ANTIMICROBIAL PEPTIDES AND METHOD FOR THEIR USE | |
EP2738255A4 (en) | PEPTIDE FROM ERAP1 AND ITS USE | |
HK1203161A1 (en) | Peptides and methods of using same | |
EP2593595A4 (en) | NOVEL PEPTIDES AND USES THEREOF | |
EP2793921A4 (en) | PEPTIDES DERIVED FROM SAPOSIN A AND USES THEREOF | |
EP2742153A4 (en) | PROTEIN AND PEPTIDE LIBRARIES | |
PL2627668T3 (pl) | Peptydy i ich zastosowanie | |
EP2740740A4 (en) | PEPTIDE DERIVED FROM A LIGAND EDAR AND USES THEREOF | |
HK1206977A1 (en) | Aromatic-cationic peptides and uses of same | |
EP2762149A4 (en) | PEPTIDE DERIVED FROM ERYTHROPOIETIN AND USE THEREOF | |
GB201121236D0 (en) | Proteins and peptides |